Intuitive Surgical (ISRG) Stock Forecast, Price Target & Predictions
ISRG Stock Forecast
Intuitive Surgical stock forecast is as follows: an average price target of $449.14 (represents a -11.49% downside from ISRG’s last price of $507.42) and a rating consensus of 'Buy', based on 16 wall street analysts offering a 1-year stock forecast.
ISRG Price Target
The average price target for Intuitive Surgical (ISRG) is $449.14 based on 1-year price targets from 16 Wall Street analysts in the past 3 months, with a price target range of $604.00 to $280.00. This represents a potential -11.49% downside from ISRG's last price of $507.42.
ISRG Analyst Ratings
According to 16 Wall Street analysts, Intuitive Surgical's rating consensus is 'Buy'. The analyst rating breakdown for ISRG stock is 0 'Strong Buy' (0.00%), 12 'Buy' (75.00%), 4 'Hold' (25.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Intuitive Surgical Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Oct 18, 2024 | David Roman | Goldman Sachs | $604.00 | $517.97 | 16.61% | 19.03% |
| Oct 18, 2024 | Shagun Singh | RBC Capital | $555.00 | $473.73 | 17.16% | 9.38% |
| Oct 18, 2024 | Adam Maeder | Piper Sandler | $538.00 | $473.73 | 13.57% | 6.03% |
| Oct 18, 2024 | Anthony Petrone | Mizuho Securities | $550.00 | $473.73 | 16.10% | 8.39% |
| Oct 18, 2024 | Rick Wise | Stifel Nicolaus | $525.00 | $473.73 | 10.82% | 3.46% |
| Oct 18, 2024 | Richard Newitter | Truist Financial | $570.00 | $473.73 | 20.32% | 12.33% |
| Oct 18, 2024 | Vijay Kumar | Evercore ISI | $490.00 | $473.73 | 3.43% | -3.43% |
| Oct 18, 2024 | Ryan Zimmerman | BTIG | $535.00 | $473.73 | 12.93% | 5.44% |
| Oct 15, 2024 | David Rescott | Robert W. Baird | $565.00 | $487.61 | 15.87% | 11.35% |
| Oct 15, 2024 | Larry Biegelsen | Wells Fargo | $466.00 | $487.61 | -4.43% | -8.16% |
The latest Intuitive Surgical stock forecast, released on Oct 18, 2024 by David Roman from Goldman Sachs, set a price target of $604.00, which represents a 16.61% increase from the stock price at the time of the forecast ($517.97), and a 19.03% increase from ISRG last price ($507.42).
Intuitive Surgical Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 12 | 14 | 27 |
| Avg Price Target | $536.75 | $534.00 | $494.56 |
| Last Closing Price | $507.42 | $507.42 | $507.42 |
| Upside/Downside | 5.78% | 5.24% | -2.53% |
In the current month, the average price target of Intuitive Surgical stock is $536.75, according to 12 Wall Street analysts offering twelve months forecast. The average price target represents a 5.78% increase as opposed to Intuitive Surgical's last price of $507.42. This month's average price target is up 0.51% compared to last quarter, and up 8.53% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Oct 18, 2024 | Piper Sandler | Overweight | Overweight | Hold |
| Oct 18, 2024 | Oppenheimer | Perform | Perform | Hold |
| Oct 18, 2024 | Evercore ISI | Cautious | Cautious | Hold |
| Oct 15, 2024 | Wells Fargo | Overweight | Overweight | Hold |
| Oct 14, 2024 | Raymond James | Outperform | Outperform | Hold |
| Oct 14, 2024 | BTIG | Buy | Buy | Hold |
| Oct 08, 2024 | RBC Capital | Outperform | Outperform | Hold |
| Oct 01, 2024 | Evercore ISI | Positive | Positive | Hold |
| Aug 28, 2024 | BTIG | Buy | Buy | Hold |
| Aug 22, 2024 | Citigroup | Buy | Buy | Hold |
Intuitive Surgical's last stock rating was published by Piper Sandler on Oct 18, 2024. The company gave ISRG a "Overweight" rating, the same as its previous rate.
Intuitive Surgical Financial Forecast
Intuitive Surgical Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $1.93B | $1.74B | $1.76B | $1.70B | $1.66B | $1.56B | $1.52B | $1.49B | $1.55B | $1.40B | $1.46B | $1.29B | $1.33B | $1.08B | $852.10M | $1.10B | $1.28B | $1.13B |
| Avg Forecast | $2.92B | $2.75B | $2.70B | $2.54B | $2.57B | $2.39B | $2.34B | $2.20B | $2.20B | $2.01B | $1.97B | $1.87B | $1.89B | $1.77B | $1.74B | $1.59B | $1.52B | $1.52B | $1.56B | $1.43B | $1.52B | $1.38B | $1.27B | $1.11B | $1.25B | $970.98M | $671.39M | $1.05B | $1.23B | $1.07B |
| High Forecast | $2.98B | $2.81B | $2.76B | $2.59B | $2.62B | $2.44B | $2.39B | $2.24B | $2.26B | $2.01B | $1.97B | $1.87B | $1.93B | $1.81B | $1.78B | $1.63B | $1.60B | $1.52B | $1.56B | $1.43B | $1.52B | $1.38B | $1.27B | $1.11B | $1.25B | $970.98M | $671.39M | $1.05B | $1.23B | $1.07B |
| Low Forecast | $2.82B | $2.66B | $2.61B | $2.45B | $2.48B | $2.31B | $2.27B | $2.12B | $2.09B | $2.01B | $1.97B | $1.87B | $1.83B | $1.71B | $1.68B | $1.54B | $1.45B | $1.52B | $1.56B | $1.43B | $1.52B | $1.38B | $1.27B | $1.11B | $1.25B | $970.98M | $671.39M | $1.05B | $1.23B | $1.07B |
| # Analysts | 10 | 7 | 5 | 5 | 8 | 5 | 4 | 11 | 16 | 8 | 5 | 10 | 11 | 5 | 5 | 9 | 5 | 4 | 4 | 7 | 5 | 5 | 10 | 7 | 9 | 9 | 9 | 9 | 5 | 5 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.02% | 0.99% | 1.01% | 1.06% | 1.09% | 1.02% | 0.98% | 1.04% | 1.02% | 1.01% | 1.15% | 1.16% | 1.06% | 1.11% | 1.27% | 1.05% | 1.04% | 1.06% |
Intuitive Surgical's average Quarter revenue forecast for Mar 24 based on 10 analysts is $1.87B, with a low forecast of $1.87B, and a high forecast of $1.87B. ISRG's average Quarter revenue forecast represents a -3.01% decrease compared to the company's last Quarter revenue of $1.93B (Dec 23).
Intuitive Surgical EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 10 | 7 | 5 | 5 | 8 | 5 | 4 | 11 | 16 | 8 | 5 | 10 | 11 | 5 | 5 | 9 | 5 | 4 | 4 | 7 | 5 | 5 | 10 | 7 | 9 | 9 | 9 | 9 | 5 | 5 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $573.40M | $465.80M | $463.20M | $387.60M | $372.50M | $398.90M | $397.60M | $408.10M | $533.00M | $536.40M | $596.00M | $511.60M | $517.90M | $421.50M | $168.80M | $368.80M | $490.50M | $448.00M |
| Avg Forecast | $833.20M | $785.86M | $771.44M | $724.52M | $732.76M | $682.57M | $668.86M | $627.40M | $628.74M | $572.51M | $562.84M | $550.10M | $539.03M | $505.25M | $497.14M | $500.09M | $577.14M | $434.99M | $445.49M | $454.63M | $434.36M | $395.23M | $361.85M | $338.47M | $356.61M | $277.19M | $191.66M | $347.02M | $351.46M | $304.41M |
| High Forecast | $851.46M | $803.08M | $788.35M | $740.39M | $748.82M | $697.53M | $683.52M | $638.96M | $645.97M | $572.52M | $562.84M | $660.12M | $550.84M | $516.32M | $508.03M | $600.11M | $692.57M | $434.99M | $445.49M | $545.56M | $434.36M | $395.23M | $361.85M | $406.17M | $356.61M | $277.19M | $191.66M | $416.42M | $351.46M | $304.41M |
| Low Forecast | $805.83M | $760.04M | $746.09M | $700.71M | $708.68M | $660.14M | $646.88M | $604.27M | $597.16M | $572.50M | $562.84M | $440.08M | $521.32M | $488.65M | $480.80M | $400.07M | $461.71M | $434.99M | $445.49M | $363.70M | $434.36M | $395.23M | $361.85M | $270.78M | $356.61M | $277.19M | $191.66M | $277.62M | $351.46M | $304.41M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.06% | 0.92% | 0.93% | 0.78% | 0.65% | 0.92% | 0.89% | 0.90% | 1.23% | 1.36% | 1.65% | 1.51% | 1.45% | 1.52% | 0.88% | 1.06% | 1.40% | 1.47% |
10 analysts predict ISRG's average Quarter EBITDA for Mar 24 to be $550.10M, with a high of $660.12M and a low of $440.08M. This is -4.06% lower than Intuitive Surgical's previous annual EBITDA (Dec 23) of $573.40M.
Intuitive Surgical Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 10 | 7 | 5 | 5 | 8 | 5 | 4 | 11 | 16 | 8 | 5 | 10 | 11 | 5 | 5 | 9 | 5 | 4 | 4 | 7 | 5 | 5 | 10 | 7 | 9 | 9 | 9 | 9 | 5 | 5 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $606.20M | $415.70M | $420.80M | $355.30M | $324.90M | $324.00M | $307.80M | $365.60M | $382.70M | $380.50M | $517.20M | $426.30M | $365.20M | $313.90M | $68.00M | $313.50M | $357.70M | $396.80M |
| Avg Forecast | $867.71M | $849.35M | $827.71M | $746.15M | $751.24M | $731.44M | $714.30M | $644.85M | $635.12M | $595.60M | $559.23M | $421.90M | $538.23M | $513.47M | $482.15M | $383.54M | $412.12M | $409.59M | $432.19M | $348.67M | $461.55M | $420.77M | $369.95M | $282.04M | $375.99M | $247.94M | $64.12M | $294.99M | $406.44M | $359.88M |
| High Forecast | $892.44M | $873.55M | $851.29M | $767.41M | $772.64M | $752.28M | $734.65M | $662.96M | $667.60M | $613.87M | $559.26M | $506.27M | $560.20M | $518.47M | $495.89M | $460.25M | $494.54M | $409.59M | $439.88M | $418.41M | $461.55M | $435.16M | $372.40M | $338.45M | $375.99M | $247.94M | $64.12M | $353.98M | $406.44M | $359.88M |
| Low Forecast | $830.65M | $813.08M | $792.35M | $714.28M | $719.15M | $700.20M | $683.79M | $623.11M | $602.64M | $577.33M | $559.20M | $337.52M | $512.60M | $508.47M | $461.56M | $306.83M | $329.69M | $409.59M | $424.51M | $278.94M | $461.55M | $406.37M | $367.50M | $225.63M | $375.99M | $247.94M | $64.12M | $235.99M | $406.44M | $359.88M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.13% | 0.81% | 0.87% | 0.93% | 0.79% | 0.79% | 0.71% | 1.05% | 0.83% | 0.90% | 1.40% | 1.51% | 0.97% | 1.27% | 1.06% | 1.06% | 0.88% | 1.10% |
Intuitive Surgical's average Quarter net income forecast for Mar 24 is $421.90M, with a range of $337.52M to $506.27M. ISRG's average Quarter net income forecast represents a -30.40% decrease compared to the company's last Quarter net income of $606.20M (Dec 23).
Intuitive Surgical SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 10 | 7 | 5 | 5 | 8 | 5 | 4 | 11 | 16 | 8 | 5 | 10 | 11 | 5 | 5 | 9 | 5 | 4 | 4 | 7 | 5 | 5 | 10 | 7 | 9 | 9 | 9 | 9 | 5 | 5 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $567.10M | $452.00M | $464.30M | $480.50M | $494.30M | $436.10M | $418.40M | $391.10M | $427.00M | $363.30M | $350.20M | $326.00M | $330.20M | $298.90M | $279.10M | $308.10M | $341.80M | $284.00M |
| Avg Forecast | $790.56M | $745.64M | $731.96M | $687.44M | $695.26M | $647.64M | $634.63M | $595.29M | $596.57M | $543.21M | $534.03M | $451.32M | $511.44M | $479.39M | $471.70M | $410.29M | $462.36M | $412.73M | $422.69M | $372.99M | $412.13M | $375.00M | $343.34M | $215.68M | $338.37M | $263.00M | $181.85M | $289.91M | $333.47M | $288.84M |
| High Forecast | $807.89M | $761.98M | $748.00M | $702.51M | $710.50M | $661.83M | $648.54M | $606.27M | $612.91M | $543.22M | $534.03M | $541.59M | $522.65M | $489.90M | $482.03M | $492.35M | $554.83M | $412.73M | $422.69M | $447.59M | $412.13M | $375.00M | $343.34M | $258.82M | $338.37M | $263.00M | $181.85M | $347.89M | $333.47M | $288.84M |
| Low Forecast | $764.59M | $721.14M | $707.91M | $664.85M | $672.41M | $626.36M | $613.78M | $573.35M | $566.60M | $543.20M | $534.03M | $361.06M | $494.64M | $463.64M | $456.20M | $328.23M | $369.89M | $412.73M | $422.69M | $298.39M | $412.13M | $375.00M | $343.34M | $172.54M | $338.37M | $263.00M | $181.85M | $231.92M | $333.47M | $288.84M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.11% | 0.94% | 0.98% | 1.17% | 1.07% | 1.06% | 0.99% | 1.05% | 1.04% | 0.97% | 1.02% | 1.51% | 0.98% | 1.14% | 1.53% | 1.06% | 1.02% | 0.98% |
Intuitive Surgical's average Quarter SG&A projection for Mar 24 is $451.32M, based on 10 Wall Street analysts, with a range of $361.06M to $541.59M. The forecast indicates a -20.42% fall compared to ISRG last annual SG&A of $567.10M (Dec 23).
Intuitive Surgical EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 10 | 7 | 5 | 5 | 8 | 5 | 4 | 11 | 16 | 8 | 5 | 10 | 11 | 5 | 5 | 9 | 5 | 4 | 4 | 7 | 5 | 5 | 10 | 7 | 9 | 9 | 9 | 9 | 5 | 5 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.18 | $1.20 | $1.01 | $0.93 | $0.91 | $0.86 | $1.02 | $1.07 | $1.07 | $1.45 | $1.20 | $1.04 | $0.89 | $0.19 | $0.90 | $1.03 | $1.15 |
| Avg Forecast | $2.39 | $2.34 | $2.28 | $2.06 | $2.07 | $2.02 | $1.97 | $1.78 | $1.75 | $1.64 | $1.54 | $1.42 | $1.48 | $1.42 | $1.33 | $1.20 | $1.13 | $1.13 | $1.20 | $1.08 | $1.28 | $1.17 | $1.02 | $0.88 | $1.04 | $0.69 | $0.18 | $0.88 | $1.13 | $1.00 |
| High Forecast | $2.46 | $2.41 | $2.35 | $2.12 | $2.13 | $2.07 | $2.03 | $1.83 | $1.84 | $1.69 | $1.54 | $1.42 | $1.54 | $1.43 | $1.37 | $1.23 | $1.19 | $1.13 | $1.22 | $1.08 | $1.28 | $1.21 | $1.03 | $0.88 | $1.04 | $0.69 | $0.18 | $0.88 | $1.13 | $1.00 |
| Low Forecast | $2.29 | $2.24 | $2.18 | $1.97 | $1.98 | $1.93 | $1.89 | $1.72 | $1.66 | $1.59 | $1.54 | $1.42 | $1.41 | $1.40 | $1.27 | $1.15 | $1.08 | $1.13 | $1.18 | $1.08 | $1.28 | $1.13 | $1.02 | $0.88 | $1.04 | $0.69 | $0.18 | $0.88 | $1.13 | $1.00 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.83% | 0.90% | 0.84% | 0.82% | 0.80% | 0.72% | 0.95% | 0.84% | 0.92% | 1.42% | 1.36% | 1.00% | 1.30% | 1.09% | 1.02% | 0.91% | 1.15% |
According to 11 Wall Street analysts, Intuitive Surgical's projected average Quarter EPS for Dec 23 is $1.48, with a low estimate of $1.41 and a high estimate of $1.54. This represents a 25.76% increase compared to ISRG previous annual EPS of $1.18 (Sep 23).
Intuitive Surgical Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| BNGO | Bionano Genomics | $0.28 | $59.33 | 21089.29% | Buy |
| COO | Cooper Companies | $104.86 | $298.00 | 184.19% | Buy |
| BAX | Baxter | $35.80 | $60.38 | 68.66% | Hold |
| TFX | Teleflex | $207.33 | $304.82 | 47.02% | Buy |
| RGEN | Repligen | $139.53 | $189.50 | 35.81% | Buy |
| BDX | Becton, Dickinson and Company | $234.33 | $283.27 | 20.89% | Buy |
| WST | West Pharmaceutical Services | $314.77 | $345.33 | 9.71% | Buy |
| MMSI | Merit Medical Systems | $99.08 | $100.78 | 1.72% | Buy |
| ICUI | ICU Medical | $172.00 | $172.00 | - | Buy |
| HOLX | Hologic | $83.72 | $80.43 | -3.93% | Buy |
| RMD | ResMed | $243.61 | $219.13 | -10.05% | Hold |
| ISRG | Intuitive Surgical | $507.42 | $449.14 | -11.49% | Buy |
| EMBC | Embecta | $14.54 | $12.00 | -17.47% | Sell |
ISRG Forecast FAQ
Is Intuitive Surgical a good buy?
Yes, according to 16 Wall Street analysts, Intuitive Surgical (ISRG) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 12 'Buy' recommendations, accounting for 75.00% of ISRG's total ratings.
What is ISRG's price target?
Intuitive Surgical (ISRG) average price target is $449.14 with a range of $280 to $604, implying a -11.49% from its last price of $507.42. The data is based on 16 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Intuitive Surgical stock go up soon?
According to Wall Street analysts' prediction for ISRG stock, the company can go down by -11.49% (from the last price of $507.42 to the average price target of $449.14), up by 19.03% based on the highest stock price target, and down by -44.82% based on the lowest stock price target.
Can Intuitive Surgical stock reach $800?
ISRG's average twelve months analyst stock price target of $449.14 does not support the claim that Intuitive Surgical can reach $800 in the near future.
What is Intuitive Surgical's current price target trend?
12 Wall Street analysts forecast a $536.75 price target for Intuitive Surgical (ISRG) this month, up 5.78% from its last price of $507.42. Compared to the last 3 and 12 months, the average price target increased by 5.24% and decreased by -2.53%, respectively.
What are Intuitive Surgical's analysts' financial forecasts?
Intuitive Surgical's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $9.5B (high $9.7B, low $9.18B), average EBITDA is $2.71B (high $2.77B, low $2.62B), average net income is $2.84B (high $2.92B, low $2.73B), average SG&A $2.57B (high $2.63B, low $2.49B), and average EPS is $7.84 (high $8.06, low $7.52). ISRG's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $10.91B (high $11.15B, low $10.55B), average EBITDA is $3.12B (high $3.18B, low $3.01B), average net income is $3.29B (high $3.38B, low $3.15B), average SG&A $2.96B (high $3.02B, low $2.86B), and average EPS is $9.07 (high $9.33, low $8.69).
Did the ISRG's actual financial results beat the analysts' financial forecasts?
Based on Intuitive Surgical's last annual report (Dec 2023), the company's revenue was $7.12B, beating the average analysts forecast of $6.99B by 1.88%. Apple's EBITDA was $2.19B, beating the average prediction of $2.04B by 7.20%. The company's net income was $1.8B, missing the average estimation of $1.92B by -6.23%. Apple's SG&A was $1.96B, beating the average forecast of $1.87B by 4.86%. Lastly, the company's EPS was $5.12, missing the average prediction of $5.43 by -5.63%. In terms of the last quarterly report (Dec 2023), Intuitive Surgical's revenue was $1.93B, beating the average analysts' forecast of $1.89B by 2.12%. The company's EBITDA was $573.4M, beating the average prediction of $539.03M by 6.38%. Intuitive Surgical's net income was $606.2M, beating the average estimation of $538.23M by 12.63%. The company's SG&A was $567.1M, beating the average forecast of $511.44M by 10.88%. Lastly, the company's EPS was $0, missing the average prediction of $1.48 by -100.00%